Phase I, open-label, single-center, multiple-dose,...

Phase I, open-label, single-center, multiple-dose, dose-escalation clinical study of SUO11248 (Sunitinib) in subjects with high-risk prostate cancer who have elected to undergo radical prostatectomy

Allan J. Pantuck, Nazy Zomorodian, Arie S. Belldegrun
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Language:
english
Pages:
2
DOI:
10.1007/s11934-007-0014-8
Date:
January, 2007
File:
PDF, 66 KB
english, 2007
Conversion to is in progress
Conversion to is failed